MVP.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: October 23, 2025
Report Source: 2025 Annual Report
Medical Developments International Ltd. Stock Analysis MVP.AX
Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Read More Medical Developments International Ltd (MVP.AX) Chart
Key Statistics of Medical Developments International Ltd (MVP.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.43Volume
67.53KP/E Ratio (TTM)
515.3552 Week Range
Market Cap
51.26MAvg. Volume
35.71KDividend Yield
-Financial Metrics & Statements of Medical Developments International Ltd (MVP.AX)
FAQ's for Medical Developments International Ltd (MVP.AX)
- According to Musaffa’s Shariah screening methodology, Medical Developments International Ltd (MVP.AX) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.